Drug Profile
BMS 189453
Alternative Names: BMS-453Latest Information Update: 20 Mar 2007
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class
- Mechanism of Action Retinoic acid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis